BCL2 and neoplasm: In many solid organ tumours, including breast cancer, BCL2 paradoxically appears to exert a tumour suppressor effect, where its expression is associated with favourable prognostic features e.g. low grade, oestrogen receptor (ER)-positivity and good outcome [21].